<DOC>
	<DOC>NCT00567424</DOC>
	<brief_summary>Study to determine drug interactions between GW273225 and the anticonvulsants valproate, carbamazepine or phenytoin</brief_summary>
	<brief_title>GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Inclusion criteria: Confident diagnosis of epilepsy Currently on VPA, CBZ or PHT &gt;or= 4 seizures/4 weeks prior to screen Exclusion criteria: Prior lamotrigine use (excluded if treatment discontinued for clinically significant safety reasons (i.e., rash, hypersensitivity)). Females of childbearing potential on hormonal contraceptives or hormone replacement therapy.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>epilepsy</keyword>
	<keyword>refractory</keyword>
	<keyword>seizure</keyword>
	<keyword>drug interactions</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>